PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 56 filers reported holding PRELUDE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $190,344 | -46.0% | 61,600 | -21.3% | 0.00% | 0.0% |
| Q2 2023 | $352,350 | -31.5% | 78,300 | -13.2% | 0.00% | -50.0% |
| Q1 2023 | $514,140 | -15.2% | 90,200 | -10.2% | 0.00% | 0.0% |
| Q4 2022 | $606,416 | -15.9% | 100,400 | -8.0% | 0.00% | 0.0% |
| Q3 2022 | $721,000 | +8.6% | 109,100 | -14.2% | 0.00% | 0.0% |
| Q2 2022 | $664,000 | +29.2% | 127,200 | +70.7% | 0.00% | +100.0% |
| Q1 2022 | $514,000 | +209.6% | 74,500 | +460.2% | 0.00% | – |
| Q4 2021 | $166,000 | -60.1% | 13,300 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $416,000 | +9.2% | 13,300 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $381,000 | -33.9% | 13,300 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $576,000 | – | 13,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 10,039,691 | $124,994,000 | 1.61% |
| Baker Brothers Advisors | 10,123,824 | $126,042,000 | 0.61% |
| Pinz Capital Management, LP | 43,800 | $545,000 | 0.21% |
| HHLR ADVISORS, LTD. | 583,333 | $7,262,000 | 0.11% |
| Rock Springs Capital Management LP | 368,959 | $4,594,000 | 0.11% |
| Nan Fung Group Holdings Ltd | 20,350 | $253,000 | 0.08% |
| Virtus ETF Advisers LLC | 13,815 | $172,000 | 0.06% |
| PDT Partners, LLC | 35,907 | $447,000 | 0.03% |
| Jump Financial, LLC | 36,900 | $459,000 | 0.03% |
| Parkwood LLC | 12,667 | $158,000 | 0.03% |